At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Scarclinic™ Thin +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.
In Brief
A clinical study evaluating Scarclinic™ Thin and Scarclinic™ Normal for Hypertrophic Surgical Scar. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Compare the efficacy and safety of Scarclinic™Thin and Scarclinic™ Normal for the treatment of surgical scars. Participant: 40 Treatment period : 3 months Medical device: Scarclinic™Thin , Scarclinic™ Normal Randomization: Table of random number
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertrophic Surgical Scar
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
Primary CompletionJul 2012
Study CompletionAug 2012
First PostedSep 2012
TodayJul 2026
First PostedSep 21, 2012
Enrollment StartOct 1, 2010
Primary CompletionJul 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.8 years ago
Interventions
Scarclinic™ Thindevice
Apply Scarclinic™ Thin on the scar and dispense 4 ea.for each participant for 3 month.
Scarclinic™ Normaldevice
Apply Scarclinic™ Normal on the scar and dispense 4 ea.for each participant for 3 month.